|
Market Closed -
Nasdaq
20:00:00 30/10/2026 GMT
|
5-day change | 1st Jan Change | ||
| 3.745 USD | -6.84% |
|
+0.40% | -43.09% |
| Market Cap | 260M 233M 214M 194M 363M 24.7B 370M 2.56B 1.03B 12.99B 976M 955M 40.97B | P/E 2026 * |
-3.59x | P/E 2027 * | -3.2x |
|---|---|---|---|---|---|
| Enterprise Value | 260M 233M 214M 194M 363M 24.7B 370M 2.56B 1.03B 12.99B 976M 955M 40.97B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 13.3x |
| Free-Float |
86.17% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| IMRX | Delayed | |
CBOE
| IMRX | Real-time |
Last Transcript: Immuneering Corporation
| 1 day | -6.84% | ||
| 1 week | +0.40% | ||
| Current month | -8.55% | ||
| 1 month | -8.55% | ||
| 3 months | -11.47% | ||
| 6 months | -28.53% | ||
| Current year | -43.09% |
| 1 week | 3.65 | 4.16 | |
| 1 month | 3.38 | 4.17 | |
| Current year | 3.38 | 8.48 | |
| 1 year | 3.38 | 8.48 | |
| 3 years | 1 | 10.08 | |
| 5 years | 1 | 31.88 | |
| 10 years | 1 | 33.99 |
| Manager | Title | Age | Since |
|---|---|---|---|
Benjamin Zeskind
CEO | Chief Executive Officer | 44 | 31/01/2008 |
Andrew Gengos
DFI | Director of Finance/CFO | 62 | 15/07/2026 |
Scott Nguyen
CTO | Chief Tech/Sci/R&D Officer | - | 31/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Robert Carpenter
CHM | Chairman | 81 | 31/12/2007 |
Benjamin Zeskind
BRD | Director/Board Member | 44 | 31/01/2008 |
Laurie Keating
BRD | Director/Board Member | 72 | 26/04/2021 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 16/07/26 | Other | Chief Financial Officer | 225,000 | 0.3478% | ||
| 16/07/26 | Free | Chief Financial Officer | 650,000 | 1.0047% | ||
| 13/03/26 | Free | Head of Human Resources | 3,628 | 0.0056% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -6.84% | +0.40% | -41.58% | -37.16% | 260M | ||
| -0.62% | +0.50% | +33.92% | +60.07% | 64.38B | ||
| +0.35% | +3.04% | +12.64% | +83.62% | 56.16B | ||
| +0.53% | +1.96% | +15.37% | +106.81% | 54.16B | ||
| -2.81% | -4.31% | +23.50% | +50.90% | 45.33B | ||
| -0.33% | -1.93% | +20.15% | +98.45% | 42.25B | ||
| +0.55% | +2.31% | +224.97% | +942.56% | 40.78B | ||
| +3.27% | +47.96% | +112.67% | +96.48% | 33.8B | ||
| +1.22% | -1.39% | +13.92% | +46.95% | 32.25B | ||
| -1.29% | -1.72% | +21.00% | -6.85% | 23.57B | ||
| Average | -0.61% | +4.88% | +43.66% | +144.18% | 39.29B | |
| Weighted average by Cap. | +0.00% | +3.75% | +49.78% | +162.51% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 19.5M 17.46M 16.06M 14.56M 27.21M 1.85B 27.72M 192M 76.9M 974M 73.18M 71.63M 3.07B |
| Net income | -74.1M -66.37M -61.05M -55.31M -103M -7.04B -105M -728M -292M -3.7B -278M -272M -11.67B | -85.92M -76.95M -70.78M -64.13M -120M -8.16B -122M -844M -339M -4.29B -322M -316M -13.53B |
| Net Debt | - | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | US$3.745 | -6.84% | 1,138,565 |
| 29/10/26 | US$4.020 | +0.75% | 777,032 |
| 28/10/26 | US$3.990 | +4.18% | 1,442,688 |
| 27/10/26 | US$3.830 | +3.23% | 700,080 |
| 26/10/26 | US$3.710 | -0.54% | 579,802 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- IMRX Stock
Select your edition
All financial news and data tailored to specific country editions

















